Table 3.
Adverse effect, severe adverse effect, concomitant medication and therapy obedience condition during 12 weeks of treatment among patients with Parkinson's diseases.
| Items | Electroacupuncture group (n = 83) | Control group (n = 83) | Difference (95% CI) | P valuea |
|---|---|---|---|---|
| Concomitant medication, n (%) | 0.508 | |||
| Yes | 29 (34.9) | 25 (30.1) | 4.8 (−9.4 to 19.1) | |
| No | 54 (65.1) | 58 (69.9) | ||
| Adverse effect, n (%)b | 0.201 | |||
| Yes | 11 (13.3) | 6 (7.2) | 6.0 (−3.2 to 15.2) | |
| No | 72 (86.8) | 77 (92.8) | ||
| Severe adverse effect, n (%) | 1.000 | |||
| Yes | 0 (0.0) | 0 (0.0) | 0 (0–0) | |
| No | 83 (100.0) | 83 (100.0) | ||
| Compliance with treatment, n (%) | 0.129 | |||
| Yes | 79 (95.2) | 83 (100.0) | −4.8 (−9.4 to −0.2) | |
| No | 4 (4.8) | 0 (0.0) | ||
| Complete treatment course, n (%) | 0.828 | |||
| Yes | 70 (84.3) | 71 (85.5) | −1.2 (−12.1 to 9.7) | |
| No | 13 (15.7) | 12 (14.5) |
a
Calculated using the chi square test.
b
Adverse effect: Electroacupuncture group: local ecchymosis (6), abdominal pain (2), dizziness (1), local hematoma (1), herpes zoster (1) and control group: headache (2), dizziness (1), fever (2), diarrhea (1).